NEW YORK, July 10 - The US Food and Drug Administration has sent a letter to the general manager of Roche Diagnostics, in Pleasanton, Calif., to discuss the appropriateness of Roche's marketing of its microarray-based AmpliChip as an analyte specific reagent (ASR) in the US, GenomeWeb has learned.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.